Absci announces collaboration with astrazeneca to advance ai-driven oncology candidate

Collaboration combines absci's ai antibody drug creation platform with astrazeneca's expertise in oncology research and development collaboration combines absci's ai antibody drug creation platform with astrazeneca's expertise in oncology research and development
ABSI Ratings Summary
ABSI Quant Ranking